Firm also agrees not to own or operate a lab within two years.
Tool will help distinguish between those prepared for a colonoscopy and those that aren’t.
Company gains $18 million in funding.
Median overall survival improved from 15 months to 21 months when combined with chemotherapy.
Bringing the world of pharma to Africa